Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TATE-PD1 in Advanced Liver Cancer
NCT03259867Phase 2Recruiting
- Sponsor
- Teclison
- Start
- Jul 2017
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tirapazamine in hepatocellular carcinoma (HCC), gastric cancer (GC), sponsored by Teclison. Started Jul 2017; status: recruiting.
02
Drugs
tirapazamine
03
Conditions
hepatocellular carcinoma (HCC)gastric cancer (GC)
Beyond the preview
Go deeper on NCT03259867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03259867.